Search research articles
Contact Us
Filters
Showing results (71-80 of 687) with videos related to
Page
of 69
Sort By:
American Journal of Hypertension
|
July 31, 2018
Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap"
Bertram Pitt, Patrick Rossignol
Circulation
|
March 27, 2023
Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension
Bertram Pitt, Anand Vaidya
JACC. Heart Failure
|
May 29, 2026
Beyond Aldosterone: Rethinking Mineralocorticoid Receptor Antagonism in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Clara Saldarriaga, Bertram Pitt
JACC. Heart Failure
|
May 8, 2025
Mineralocorticoid Receptor Antagonist Use in Hypertension to Prevent Heart Failure
Bertram Pitt, Anand Vaidya
Journal of the American Heart Association
|
December 25, 2017
Mineralocorticoid Receptor Antagonists in High-Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease
Bertram Pitt, Patrick Rossignol
Clinical Kidney Journal
|
June 30, 2015
Erratum: Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease
Eberhard Ritz, Bertram Pitt
Cardiology
|
April 4, 2009
The role of aldosterone blockade in end-stage renal disease
Bertram Pitt, Rajiv Saran
Circulation. Cardiovascular Imaging
|
January 19, 2012
The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?
Bertram Pitt, Faiez Zannad
European Journal of Heart Failure
|
February 16, 2023
Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?
Patrick Rossignol, Bertram Pitt
Hypertension (Dallas, Tex. : 1979)
|
May 8, 2024
Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease
Bertram Pitt, Javier Diez
Page
of 69
Search research articles
Search
Showing results (71-80 of 687) with videos related to
Sort By:
Page
of 69
American Journal of Hypertension
|
July 31, 2018
Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap"
Bertram Pitt, Patrick Rossignol
Circulation
|
March 27, 2023
Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension
Bertram Pitt, Anand Vaidya
JACC. Heart Failure
|
May 29, 2026
Beyond Aldosterone: Rethinking Mineralocorticoid Receptor Antagonism in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Clara Saldarriaga, Bertram Pitt
JACC. Heart Failure
|
May 8, 2025
Mineralocorticoid Receptor Antagonist Use in Hypertension to Prevent Heart Failure
Bertram Pitt, Anand Vaidya
Journal of the American Heart Association
|
December 25, 2017
Mineralocorticoid Receptor Antagonists in High-Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease
Bertram Pitt, Patrick Rossignol
Clinical Kidney Journal
|
June 30, 2015
Erratum: Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease
Eberhard Ritz, Bertram Pitt
Cardiology
|
April 4, 2009
The role of aldosterone blockade in end-stage renal disease
Bertram Pitt, Rajiv Saran
Circulation. Cardiovascular Imaging
|
January 19, 2012
The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?
Bertram Pitt, Faiez Zannad
European Journal of Heart Failure
|
February 16, 2023
Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?
Patrick Rossignol, Bertram Pitt
Hypertension (Dallas, Tex. : 1979)
|
May 8, 2024
Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease
Bertram Pitt, Javier Diez
Page
of 69